Latest filing published 15 Dec 2023 for Cytosorbents Corp, €9,261.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -50.3%Entry US$36.60 · Close at T+365 US$18.20
- +60.5%Entry US$44.60 · Close at T+365 US$71.60
- +188.6%Entry US$79.00 · Close at T+365 US$228.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Edward Raymond Jones: trading record in brief
Edward Raymond Jones is a declared insider of Cytosorbents Corp (board member), with filings sourced from SEC (Form 4). We count 11 filings; the first trade dates from 8 April 2015 and the latest from 13 December 2023.
Every open-market trade on record is a purchase: 4 purchases worth €22k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants and 2 option exercises. In 2023 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €5,372. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 4 purchases show a median change of +17.6%, with the price up in 50% of them. These figures describe past trades and do not predict future prices.
Most recently, on 15 December 2023, the filings show an open-market purchase worth €9,261 in Cytosorbents Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Edward Raymond Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,519 shares@ US$1.3333.8% of flowCommon StockSEC:0001104659-23-126428:0Canonical exit: 12 Mar 2024 (T+90)
- 1,676 shares@ US$2.236613.1% of flowCommon StockSEC:0001104659-22-061986:0Canonical exit: 14 Aug 2022 (T+90)
- 3,161 shares@ US$5.2223.4% of flowCommon StockSEC:0001104659-21-149251:1
- 4,000 shares@ US$4.12553.1% of flowCommon StockSEC:0001104659-21-149251:0
- 4,000 shares@ US$3.3529.0% of flowCommon StockSEC:0001104659-20-097228:0
- 3,300 shares0Common StockSEC:0001144204-18-022968:0
- 500 shares@ US$3.983.7% of flowCommon StockSEC:0001144204-17-031784:0Canonical exit: 6 Sept 2017 (T+90)
- 2,000 shares@ US$4.0015.0% of flowCommon StockSEC:0001144204-17-031784:1Canonical exit: 6 Sept 2017 (T+90)
- 6,000 shares0Common StockSEC:0001144204-17-011830:0
- 5,000 shares0Common StockSEC:0001144204-16-107736:0
- 55,000 shares0Common StockSEC:0001144204-15-022341:0
11 of 11 declarations
